{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:24:53Z","timestamp":1715646293321},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,11,1]]},"DOI":"10.2169\/internalmedicine.0761-22","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T22:11:01Z","timestamp":1689113461000},"page":"3125-3130","source":"Crossref","is-referenced-by-count":2,"title":["Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19"],"prefix":"10.2169","volume":"62","author":[{"given":"Ryo","family":"Nagasawa","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"},{"name":"Department of Pulmonology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Niwa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneyuki","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Okuda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med 383: 1813-1826, 2020.","DOI":"10.1056\/NEJMc2022236"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395: 1569-1578, 2020.","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395: 1033-1034, 2020.","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kim JS, Lee JY, Yang JW, et al. Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics 11: 316-329, 2021.","DOI":"10.7150\/thno.49713"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384: 693-704, 2021.","DOI":"10.1056\/NEJMoa2021436"},{"key":"6","unstructured":"6. Kalil AC, Patterson TF, Mehta AK, et al. Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med 384: 795-807, 2021."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Izumo T, Kuse N, Awano N, et al. Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19. Respir Investig 59: 799-803, 2021.","DOI":"10.1016\/j.resinv.2021.07.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Salvarani C, Massari M, Costantini M, et al. Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial. Eur Respir J 31: 2200025, 2022.","DOI":"10.1183\/13993003.00025-2022"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shindo Y, Kondoh Y, Kada A, et al. Phase II clinical trial of combination therapy with favipiravir and methylprednisolone for COVID-19 with non-critical respiratory failure. Infect Dis Ther 10: 2353-2369, 2021.","DOI":"10.1007\/s40121-021-00512-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. L\u00f3pez Z\u00fa\u00f1iga M\u00c1, Moreno-Moral A, Oca\u00f1a-Granados A, et al. High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyperinflammatory response. PLoS One 16: e0243964, 2021.","DOI":"10.1371\/journal.pone.0243964"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ikeda S, Misumi T, Izumi S, et al. Corticosteroids for hospitalized patients with mild to critically ill COVID-19: a multicenter, retrospective, propensity score-matched study. Sci Rep 11: 10727, 2021.","DOI":"10.1038\/s41598-021-90246-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Murohashi K, Hagiwara E, Kitayama T, et al. Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: a report of 11 cases. Respir Investig 58: 430-434, 2020.","DOI":"10.1016\/j.resinv.2020.08.001"},{"key":"13","unstructured":"13. Munch MW, Myatra SN, et al.; COVID STEROID 2 Trial Group. Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 Randomized Trial. JAMA 326: 1807-1817, 2021."},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Bouadma L, Mekontso-Dessap A, Burdet C, et al. High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure: the COVIDICUS Randomized Clinical Trial. JAMA internal medicine 182: 906-916, 2022.","DOI":"10.1001\/jamainternmed.2022.2168"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pinz\u00f3n MA, Ortiz S, Holgu\u00edn H, et al. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia. PLoS One 25: e0252057, 2021.","DOI":"10.1371\/journal.pone.0252057"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/21\/62_0761-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:29:37Z","timestamp":1715574577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/21\/62_0761-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":15,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0761-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"article-number":"0761-22"}}